Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 30068 | 143 | 25.7 | 44% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2282 | 4190 | INTERSTITIAL CYSTITIS//CYSTITIS INTERSTITIAL//PAINFUL BLADDER SYNDROME |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | N N N TRIETHYLENEPHOSPHORAMIDE | Author keyword | 4 | 75% | 2% | 3 |
| 2 | THIOTEPA MERCAPTURATE | Author keyword | 3 | 100% | 2% | 3 |
| 3 | TEPA | Author keyword | 3 | 37% | 5% | 7 |
| 4 | THIOTEPA | Author keyword | 3 | 13% | 15% | 21 |
| 5 | N N N TRIETHYLENETHIOPHOSPHORAMIDE | Author keyword | 3 | 60% | 2% | 3 |
| 6 | THIO TEPA | Author keyword | 1 | 38% | 2% | 3 |
| 7 | MONOCHLOROTEPA | Author keyword | 1 | 100% | 1% | 2 |
| 8 | SODIUM CHLORIDE CATALYZED DEGRADATION | Author keyword | 1 | 100% | 1% | 2 |
| 9 | THIOTEPA AND TEPA | Author keyword | 1 | 100% | 1% | 2 |
| 10 | 5 FLUOROURICIL | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | N N N TRIETHYLENEPHOSPHORAMIDE | 4 | 75% | 2% | 3 | Search N+N++N++TRIETHYLENEPHOSPHORAMIDE | Search N+N++N++TRIETHYLENEPHOSPHORAMIDE |
| 2 | THIOTEPA MERCAPTURATE | 3 | 100% | 2% | 3 | Search THIOTEPA+MERCAPTURATE | Search THIOTEPA+MERCAPTURATE |
| 3 | TEPA | 3 | 37% | 5% | 7 | Search TEPA | Search TEPA |
| 4 | THIOTEPA | 3 | 13% | 15% | 21 | Search THIOTEPA | Search THIOTEPA |
| 5 | N N N TRIETHYLENETHIOPHOSPHORAMIDE | 3 | 60% | 2% | 3 | Search N+N++N++TRIETHYLENETHIOPHOSPHORAMIDE | Search N+N++N++TRIETHYLENETHIOPHOSPHORAMIDE |
| 6 | THIO TEPA | 1 | 38% | 2% | 3 | Search THIO+TEPA | Search THIO+TEPA |
| 7 | MONOCHLOROTEPA | 1 | 100% | 1% | 2 | Search MONOCHLOROTEPA | Search MONOCHLOROTEPA |
| 8 | SODIUM CHLORIDE CATALYZED DEGRADATION | 1 | 100% | 1% | 2 | Search SODIUM+CHLORIDE+CATALYZED+DEGRADATION | Search SODIUM+CHLORIDE+CATALYZED+DEGRADATION |
| 9 | THIOTEPA AND TEPA | 1 | 100% | 1% | 2 | Search THIOTEPA+AND+TEPA | Search THIOTEPA+AND+TEPA |
| 10 | 5 FLUOROURICIL | 1 | 50% | 1% | 1 | Search 5+FLUOROURICIL | Search 5+FLUOROURICIL |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | N N N TRIETHYLENETHIOPHOSPHORAMIDE | 14 | 55% | 12% | 17 |
| 2 | HUMAN PLASMA PHARMACOKINETICS | 7 | 64% | 5% | 7 |
| 3 | HIGH DOSE THIOTEPA | 6 | 58% | 5% | 7 |
| 4 | N N N TRIETHYLENEPHOSPHORAMIDE | 6 | 100% | 3% | 4 |
| 5 | TRIETHYLENETHIOPHOSPHORAMIDE | 6 | 100% | 3% | 4 |
| 6 | TEPA | 5 | 50% | 5% | 7 |
| 7 | THIO TEPA | 2 | 33% | 3% | 5 |
| 8 | DRUG THIOTEPA | 1 | 50% | 1% | 1 |
| 9 | THIOTEPA PHARMACOKINETICS | 1 | 50% | 1% | 1 |
| 10 | VATH | 1 | 50% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Chemistry, pharmacology and pharmacokinetics of N,N ',N ''-triethylenethiophosphoramide (ThioTEPA) | 2000 | 16 | 77 | 64% |
| Individualization of cancer therapy based on cytochrome P450 polymorphism: a pharmacogenetic approach | 1997 | 9 | 89 | 11% |
| APPLICATION OF SOFT-IONIZATION MASS-SPECTROMETRY IN BIOCHEMISTRY | 1989 | 1 | 12 | 33% |
| HIGH-DOSE CHEMOTHERAPY REGIMENS FOR SOLID TUMORS | 1995 | 33 | 100 | 8% |
| Soft-ionization mass spectrometry study of deoxynucleoside bioclusters and deoxynucleoside-antitumor medicinal preparation clusters | 1995 | 4 | 32 | 16% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PEDIAT EMATOL ONCOL 4 | 1 | 50% | 0.7% | 1 |
| 2 | REPROD MED DEV | 0 | 25% | 0.7% | 1 |
| 3 | PHYSICOCHIM THEOR CHIM INFORMAT | 0 | 10% | 0.7% | 1 |
| 4 | HOSP ITALIANO CORDOBA | 0 | 100% | 0.7% | 1 |
| 5 | PHARM PHARAMCOL | 0 | 100% | 0.7% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000214406 | IFOSFAMIDE//TROFOSFAMIDE//BNP7787 |
| 2 | 0.0000192571 | HIGH DOSE CHEMOTHERAPY//DOSE INTENSITY//HIGH RISK BREAST CANCER |
| 3 | 0.0000187313 | POTENTIAL MUTATIONS//RARE TAUTOMERIC FORMS//SOS REPLICATION |
| 4 | 0.0000186920 | BENZOYLATED DEAE CELLULOSE CHROMATOGRAPHY//POLYADENOSINE DIPHOSPHATE RIBOSE//N NITROSO N ETHYLUREA |
| 5 | 0.0000141708 | CELL MED//H 1 CELLS//H1 CELLS |
| 6 | 0.0000108926 | PEPTICHEMIO//ALKYLATING PEPTIDES//HUMAN MYELOMA CELLS |
| 7 | 0.0000092269 | NBD GLUCOSAMINE//// |
| 8 | 0.0000091508 | SARCNU//TAUROMUSTINE//S 2250 KAWAGISHI |
| 9 | 0.0000087946 | BUSULFAN//TREOSULFAN//INTRAVENOUS BUSULFAN |
| 10 | 0.0000082633 | LIVER SLICES//PRECISION CUT TISSUE SLICES//PRECISION CUT LIVER SLICES |